BioCardia, Inc.
BioCardia, Inc. (BCDA): 7 pipeline candidates · ~2 mo cash runway. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
1.8 months
D/E -2.61 · 0% dilution
Lead: Phase 3
7 candidates
N/A
13 buys · 0 sells (180d)
A transparent, data-derived signal for BioCardia, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$12.4M
Cash
$951K
Quarterly Burn
$1.7M
Runway
1.8 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (7 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
15
Total value held
$756K
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 249,182 | $302K |
| geode capital management, llc | 94,287 | $114K |
| vanguard fiduciary trust co | 66,270 | $80K |
| citadel advisors llc | 63,384 | $77K |
| susquehanna international group, llp | 38,827 | $47K |
| brown advisory inc | 35,538 | $43K |
| xtx topco ltd | 24,270 | $29K |
| commonwealth equity services, llc | 18,283 | $22K |
| two sigma securities, llc | 14,780 | $18K |
| renaissance technologies llc | 13,900 | $17K |
Showing top 10 of 15 institutional holders of BioCardia, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in BioCardia, Inc.'s pipeline?
BioCardia, Inc. (BCDA) has 7 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is BioCardia, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, BioCardia, Inc. has approximately 1.8 months of cash runway.
What is BioCardia, Inc.'s market capitalization?
BioCardia, Inc.'s market capitalization is approximately $12.4M.
Who is the CEO of BioCardia, Inc.?
Dr. Peter A. Altman Ph.D. is the chief executive officer of BioCardia, Inc. (BCDA).
Get the full picture on BioCardia, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.